CT Germer

Papers

Total Citations

H-Index

About

Dr. CT Germer is a leading figure in surgical oncology, with a focused expertise in hereditary colorectal carcinomas and minimally invasive endocrine surgery. His work critically addresses operative strategies for patients with genetic predispositions to colorectal cancer, providing evidence-based frameworks that guide complex clinical decision-making. In parallel, Dr. Germer has advanced the field of robotic adrenal surgery, synthesizing current evidence to evaluate the safety, efficacy, and technical nuances of robotic approaches compared to traditional laparoscopy. His 2023 paper on hereditary colorectal carcinoma operative strategies and his 2024 review of robotic adrenal surgery each have garnered early attention with 2 citations, reflecting their emerging impact in specialized surgical communities. Dr. Germer’s contributions are particularly notable for bridging the gap between genetic risk assessment and tailored surgical intervention, as well as for championing the adoption of robotic technology in endocrine procedures. His work serves as a vital resource for surgeons and researchers seeking to optimize outcomes in both colorectal and adrenal surgery, marking him as a thoughtful innovator in precision surgical oncology.